STAA - Earnings call transcript Q2 2024

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

[Audio Gap] and strategic agreements, supporting healthcare professional level marketing campaigns and amplifying compelling proof points, which demonstrate the patient and practice benefits of selecting the EVO procedure. And third, driving innovation in key technical and product areas of our business, which I will discuss later in more detail.

Turning to our performance by region. In our Americas region, we generated sales growth of 14%, including U.S. sales growth of 25% year-over-year and 10% sequentially.

U.S. the on focus Our business, with XX through Highway key emphasis is bearing on initiative, accounts fruit. our an

We in are surgeons effectively with seeding evident the market by sales U.S. the States. XX% accounts. quarter second XX progress was quarter results Growth influential in percentage half United growth our accounts XX some XX points of first establishing most the and Highway for the the high-volume in The is of meaningful relationships of XX%, non-Highway for XXXX. above and U.S. the second

driven encouraged backdrop exceeding STAAR In in the EMEA, by our conflicts sales markets markets XX% European and we are the the region. and in are invested have personnel East, results, generated given and our where growth, outlook. Spain. we These new Growth was initiatives, macroeconomic Middle distributor we by and

X% the growth was generated expectations people procedure. ICL XX% we high sales our the high and the of In season in June, APAC, many with historical By halfway encouraged in growth early similar China, EVO remain year-over-year EVO a we in-market we're quarter, refractive by country, second we to to in have when entered and for sales sequentially. elect implants young Today, consistent since and our trends season, China through activity. XXXX. In sequential

is laser correction EVO a market of in vision ICL where half about sales positive of the legacy illustrates in growth refractive predominant advantages Our XXXX. XX% first procedure, the China the for down

$XXX our for would represent of team. to million, annual over growth which XX% remain approximately in track on fiscal sales milestone China China, STAAR another significant we achieve XXXX, For and China sales

of vision commands our the where market for EVO correction. refractive Japan, care largest as the to Turning ICL share standard

benefit with from approximately continues procedure. from yen, a leaders We continue opinion organization were XX%, of Japan STAAR headwinds with up sell the market, in in second quarter Despite to level XX a market. EVO an sales to key where for significantly weak units direct higher. the very the nicely currency this through high professionals, The Japan of we enthusiastic in confidence grow

Korea. sales XX% second to growth Turning in quarter. generated South the We

and The Korea a following ICL-only clinic first exist ICL-only first Korea, We clinics of to this successful start. good could in year, ICL-only Japan. in clinics the off in anticipate already be opened of is and China earlier the South the clinic that and thrive many path South

outlined lens is of commercial ICL all Globally, EVO technology The correction the LASIK, vision procedures, momentum our I outpace indicates laser just including SMILE. our to cylinders. that lens growth PRK and technology on continues firing

the over than winning We're the first X.X we levels half taking of to of minus successfully both for expanding overall lower moving X.X We're opportunity The diopter the ICL in globally in average diopter share market vision diopters, XXXX process. patients, our down of EVO growth are surgeons correction. XXXX. lower proprietary was and diopter curve fiscal sold and lenses, the

progress X Finally, X XX% market increases our the contributing of to globally. our and in half increased mix sold This to addressable points lenses is first minus XXXX. gains of our and total market diopters share below continuing

our initiatives We telling they term. priorities market letting been you strategic long on results are and about, effectively we've and near up that are not as position strengthening the and

today. reported first in reflected the that half QX see and You results we

update results, on illustrate you Following that additional detailed Patrick? review initiatives growth company's immense of I our will some Patrick's financial our opportunity.

Patrick Williams

$X.X million million sales quarter. ICL or a quarter, our XXXX million and seasonally in a you, for sales million, $X.X other X% the to strongest QX increase to is everyone. of in sales Thank QX million increase XXXX, The good net Tom, increase in net net as in year $XX a were compared products. afternoon, $XX.X $X.X sales Total attributable and prior

currency FX today, to for sales the compared which due the Constant QX year strong adjusts to prior sales Japan. $XXX.X for period, as largest our were headwinds market second X% XXXX up U.S. million, net dollar and

in net XXXX, $XX of IOLs to or margin For net or for to gross QX million million compared quarter year to quarter. $XX.X primarily and the of prior net gross was or increase X.X% is of cataract XXXX. sales of profit The as XX.X% XX.X% profit the due in year year-over-year for in prior sales, gross $XX.X related changes million reserves sales QX

a company fiscal business XXXX. exited IOL the reminder, in its As cataract

each XXXX, For for expect to quarter. be XX% approximately remaining we continue will gross margin

lean improve to expansion, the EVO investments we for a expenses growth. as drive the investments prior operating to margin QX surgeon build experience statement. million tools decision to surgeon lay ICL $XX.X $XX.X market operating future education, down quarter million and $XX.X and as were Total in to XXXX. compared Moving in sales foundation increase to income into our teams The year long-term for QX for expenses including growth XXXX in to and reflects million in

Taking expenses, QX in to a outside $XX.X million million the and services. million The year-over-year is XXXX. look increase the primarily closer compensation-related expenses, facilities components costs operating $XX.X expense was year QX increased prior for of $XX.X compared due in to XXXX in at and G&A G&A quarter

be to $XX For to million expect approximately quarter. G&A expense continue XXXX, per we

in marketing $XX.X quarter. activities activities company from million due marketing with in the promotion year expenses million and expense and in advertising our higher shifted variable decrease $XX.X and $XX.X promotion marketing related sequential marketing, is the to second and marketing awareness compared the dollars quarter to the associated activities and XXXX. the practice marketing sales to in XXXX year prior million the brand QX as QX was expense at and increase prior in The lower to The was level. for selling selling Selling

expect $XX and approximately quarter. marketing per selling For XXXX, continue will expense we to million be

XXXX. The was clinical lower due expenses, in trial year-over-year QX offset expense for development the increase XXXX is QX compensation-related compared partially prior $XX.X in $XX.X and for costs. and R&D to quarter by million million Research year $XX.X to million

independent investments XXXX, global half second AI-related in the R&D $XX up education expense For reflecting accelerate and per to now technology slightly ICL. expect be to adoption training studies of and investigator focused EVO quarter, of at innovations, approximately million we

XXXX, $X.X QX prior income net compared income to in QX or XXXX of net EBITDA quarter. Adjusted $XX.X diluted $X.XX or earnings of year million quarter. million year to the the million of earnings share per share $X.X GAAP diluted diluted in compared $X.XX diluted million prior adjusted $X.XX or share was $XX.X per per For per for EBITDA or $X.XX share

$XXX $XXX fiscal markets. million in $X are which we our sales to million outlook industry-leading growth key million, contemplates said, to XXXX Tom raising all As range a of

For quarter anticipate million. net XXXX, $XX the of third we approximately sales of

third the million. reflecting We by summer of QX sales results anticipate the followed U.S. to above in the sales seasonality, U.S. also a of approximately $X.X million $X reacceleration million our fourth $X.X of quarter, in quarter

raising previously. fiscal our we per from for $XX are XX full EBITDA approximately approximately on now Using XXXX. outlook, million higher adjusted sales share, $X.XX to Based by be is shares and million adjusted million, approximately our up diluted EBITDA $X.XX adjusted per $X outstanding, year outlook approximately approximately share for anticipate EBITDA now our

press release of measures non-GAAP today's and earnings in financial reconciliation presentation. shown A earnings is

presentation XX and For please Slides additional modeling detail for XX earnings this item line and to of specific updates. purposes, refer

EMEA, By the growth of and outlook our driven we by in to U.S. XX% Americas, up region, growth XX%, you now can growth prior flat outlook XX% see the expect our in outlook. versus previously, where versus increase X%

region. to key the expect which We refractive this would APAC our continue growth fastest X% industry in in for growth region, be the

our XXXX, fiscal of new increase net in our For for sales. half increased U.S. the global represents outlook outlook new about for $X million the

Turning sheet. now to balance our

cash, million QX for as were million at fiscal cash to $XXX.X investments for available Our $XXX.X year-end and XXXX. equivalents end compared the of XXXX sale

about As a is XX reminder, our DSO days.

collect in third record cash will for We sales QX our the quarter. quarter

days Conference Sachs in and European London meeting meetings XX, Conference West conferences the We trip, Sidoti you the Boston, Services includes A many in West Europe look list Medtech Blair Slide field trip, Healthcare as the to on field conferences the and Piper forward weeks shown at the Canaccord and Conference. of here investor Virtual Sandler Coast Goldman the Growth Asia. and with Small-Cap William the and Coast and ahead U.S., of in in

adding Asia-based for Investor the STAAR community. professional Relations a an resource as Finally, investment we are

normal Mainland China In and course Hong we conferences, November. do for our And Tom. of investor also addition to meetings to QX. Kong in will report now to We expect in have investor early in-person back results QX

Thomas G. Frinzi

and accelerating. XXXX, We exceeded first of Thank is momentum targets met our half you, Patrick. commercial in our the or

ICL adoption. design deep with needs customer of allowed global surveys us We customers of friction the understanding programs XXXX, broaden Our way. reduce engagement surgeon significantly the and conducted to is EVO our in speed X and to which customers guiding our our

X,XXX U.S. We customer Congress shows the with recently cataract among in significantly commissioned U.S. X% surgeons. ICL mix represents are commissioned data surgeons, The vision with past. XX% these the approximate building American-European and in that an leading-edge refractive upon of EVO a share approximately study mentioned U.S. is The of refractive Surgery. this we market ACO June refractive Ophthalmic ACO the the procedures the laser- analyzed It organization procedures. across today. overall and focus correction in in study above procedure lens-based commands we U.S. I've our the

diopters surgeon illustrates market than the implanted total minus nearly versus data addressable average opportunity the more XX surgeons The for surgeons U.S. the United but moved bigger. X.X quickly also ACO larger overall. States, Surveyed all down have EVO our diopter even ACO's minus The curve ACO certified. market is ICL in diopter our diopters is U.S.

from represents on annual an million currently moving $XX see can U.S. X% the additional and procedures with you U.S. Slide As XX% surgeons ACO share the to sales. XX, share in in XX,XXX today

share markets, XX% to States this sales. in equates Assuming large as annual million we United other U.S. have in reach in $XXX the we

market, done other the eyes these to in have bigger And in the what U.S. vectors with States, our on intend the million the believe even data, do XX which envisioned. us However, originally growing business none U.S. and we I based United now I geographies, range. that of can growth than approved ACO's contemplated in be

We are levers important learning, which growth opportunity. are to and most accelerate tremendous the our market listening realize and

in we're experience surgeon innovating First, and education.

and ago are and ordering time customers affairs by XX%. over site, website, surgeon globally. STAAR receiving already Both medical Stella new system, order surgeon months the delivers from needed a United and new few cuts STAAR our a being and their and streamlined University to just launched Our praise which States, feedback workflow staff. Stella education which is in positive is expanded our University more

already EVO Next a with planned of hub throughout open Experience live previous week, at events The our Lake year. Forest, center education, practice than brand-new of center serve and larger California end surgeon is Center we as full headquarters. the the our ICL significantly state-of-the-art will will STAAR's slate and a of ophthalmic

innovating procedures. of we confidence. drive in U.S.-based Secondly, clinical final We're head-to-head study the versus vision are to stages new a developing correction laser

will satisfaction are demonstrate We including further advantages, of quality results range. and vision approved EVO's high the diopter patient across confident the that

with And finally, working guide the to investing our surgeons in technology we're are of potential our working AI-based measurement selection. globally. We harmonization market protocols through to size label expand advance and indications and to

for compelling. The investment is Surgical STAAR one, Number case our product.

EVO of the and and a solutions, that We product, the where set for which refractive broader future. patients in market them have give are differentiated proprietary more surgeons options disrupting a looking is ICL,

will X high billion market. X with myopia. have By XXXX, people billion our myopia, including Secondly,

and globally, So growing. as immense opportunity market including such markets the emerging is total and India addressable Brazil,

the to legacy Just of as continues laser the and interest procedure, vision predominant decline. penetration correction,

and Third, process. people our our

We we'll And vital on continue employees. X,XXX-plus our facts, the data needed. few high-performance and to team year, bolster a and process improvement to all and priorities. to we as in STAAR process management our strengthen continuous around execute, introduced January this of teams, based strategic the have We cascaded

financial our Fourth, model.

cash demonstrated generate strong in We high a have invest prudently margins model, business a to sustain and gross our and business. with ability to

with on market our of driving that STAAR, leads practice. the is differentiator EVO before implements to surgeon all ICL in the change eyes. competitive accelerators identifying be are watching their in And building a momentum. investing EVO that customer, we every At right to and focus proving and

Vision starting your today into target. laying plus covered is Thank and sales translate are sales you for foundation evolution towards XXXX XXXX to growth, happening. I've million for an the our future acceleration attention. Clearly, initiatives into The better $XXX

questions. now we'll take any operator, And

Operator

Instructions] will [Operator BTIG. be Ryan with first from Zimmerman question Our

Ryan Zimmerman

I I guys hear you did right. Okay. unmuted. Can okay? Hopefully, me that

Thomas G. Frinzi

hear we Yes, Ryan. you,

Ryan Zimmerman

Wonderful.

-- the all was Okay. That at my fear biggest right.

So about I China. ask want to

been it's -- kind peers Just There's China topical. of some the obviously refractory in of messages mixed very of terms market. about in your

China, of X.X% just XX%. first half You guys did about in guidance the growth to

your longer informs around 'XX? views of of the are your recovery what potentially in of to growth what health in and talk half So China about kind second us mid-teens the consumer profile prevailing in term? And

Thomas G. Frinzi

we to the today, we good China. here from in we about Ryan, Yes. Again, and for thanks as hear question. good sit look, are you, where feel

think If areas for whether around, that seem anticorruption, really minimal, questions if economy, X the it's of X about or whether headlines you the say it's have lot any, out people whether it's to PPP, in it's a have those would impact whether I of business. competition, our the

not business, clearly, grow. today we taking are. very good we market Economy, But with pleased the We're for a and the see. season, business, you where the certainly continue but we're our high and we we tomorrow. feel same as our We In to headwinds about at share, only through some market, declining there. first there's we things read look halfway know half out through

Operator

come Our next Stifel. question at Stephan will from Tom

Thomas Stephan

me you Can hear okay? guys Okay.

Thomas G. Frinzi

Yes, we Tom. can,

Thomas Stephan

if about that's wanted right. Perfect. start as I to if upfront. XXXX, can Good. both I Maybe all ask

think grew modeled think X% XX% implies into about XXXX? you accelerating in or Patrick are XH. afternoon. I revenue in Street growth I growth X% of early growth in thoughts Guidance this your Tom, coming what again XH.

type that And as reacceleration follow-up. with year maybe comfortable hopefully, quicker today? we a here you next of Are sit then

Refractive U.S. there, at relates put I M&A, the the that are of out stock the markets it's early. now levels. on point, time your a as pre-COVID understand obviously, from but perspective? why I is back part for the low is arguably end to an were Just STAAR responsibilities, M&A and it at mean, fiduciary would be still so right headlines

long-term if for bit you So maybe on, the vision kind can I elaborate your motivation of a guess, STAAR? and company's

Patrick Williams

Tom. guidance XX% a give one, was XXXX first or did we which XX% be at out CAGR. the Vision to we're But XXXX to not this take guidance giving even I'll point. Look, out fair, our X-year there, beyond

we And we are good plan. months feel remarks, so a where about as X his prepared XX-month Tom said into in X,

XXXX, initial the apparent. think revenue in see which digit is I the question board. to we reacceleration growth mid-teen of across half maybe a in have the was very going to second double We're

this effect. And through out things putting year, we judge we're as got so the move we them we really us that it let's in to give some but all place, take believe to time

much XXXX that result Tom and curve will lot his a diopter closing moving about of the geographies outlined quicker conviction down hitting really that of adoption good There's in all the in believe that more stuff around that statements we ultimately. in a Vision world, gives us

Thomas G. Frinzi

around to our your I And We're we're Tom, head on globe. that's our frankly, down. our is M&A around continuing business are on I've to think, activity, rumors execution, quite but they look, as what what focused times, from focused the are, business, And grow and matters many question said us.

Operator

with Our William Kaczor question Andrew Margaret from be Blair. next will

Margaret Kaczor

I'm me else hear going say, to you do what "Can asked everyone now?" and

Thomas G. Frinzi

can. We

Margaret Kaczor

it. Appreciate All right.

a talk bit to about was hoping I little U.S. So the

row, get as seeing XX% QX. are QX into QX. now comments And traction the some we in some nice a sequentially X quarters in around sequential I go up seasonality guys of You and

But it equal all pretty flat saw in seems being what average, similar, QX sequentially things we from dollars. in on

accounts? accounts, I is the new traction guess the in increases those when guidance guys significant And feel in view, especially U.S.? XX is, net-net, sequential enough Highway with start not So in that XX that you you're guess, that seeing conservative in more traction sequential continued in of and increase seeing we're comfortable your all seeing to maybe Highway will assuming I

Thomas G. Frinzi

Margaret. Listen, sure. Yes, the question, thanks for

might about Patrick the you've where I to jog And were business, probably the from anecdotally, we I heard crawled. feel U.S. to remarks the to running for analogy, if I, think XXXX. starting in think is. prepared we'll and end year, We of the use We're by in and I we said as an good our we U.S. be and start walk.

good really growth we really term about cadence mean are kind right ourselves out think I sustainable. the of we're I near I All up that's both well we're received. doing. And long of term being for -- and So the feel rolled what initiatives setting

signed, So everything pending, contracts have, we've the cylinders. that on we contracts all the initiatives the clicking are is

just again, be don't prudent. want ourselves. would to [indiscernible]. We trying just say think get of We're I So we're be good, our I out ahead to our but balanced. trying very feel about to But only we hits U.S. business, not business where

Brian Moore

take let's please. . Thank question, Zimmerman's you, Ryan moderator. Moderator, second

Operator

your and question. go Ryan, ahead do. We'll ask Perfect.

Ryan Zimmerman

I a first. in just And laid refractive you're... ask slide particularly the of the this you and about similar to to of But second market, it kind out question, want growth Tom, U.S. was my

Thomas G. Frinzi

Ryan -- Ryan. up, breaking you're

Patrick Williams

and question. your Ryan, repeat pause you let's

Difficulty] [Technical

Brian Moore

Going back you, to Ryan.

Thomas G. Frinzi

Try into cell a here, stronger service to get Ryan.

Brian Moore

to question. come Ryan. Moderator, next back let's the to We'll go you,

Operator

Our next Saxon be question David from at Needham. will

David Saxon

okay? you Yes. me hear Can

Thomas G. Frinzi

we Yes, can.

David Saxon

China that's for Okay. with account Maybe I'll Great. Aier. start know I in a key you guys.

for there were reports there Aier think some their I lower LASIK. that pricing

So it's ICL about procedure of pricing. half

Just you any move impact from given there, seen from over them? pricing that the consumer have

it know as they -- And relates XX I all think hospitals strategy so. mean, acquired I Aier, just to last secondarily, more in the M&A. then we And week they or involves their

So hospitals Are how as to into strategy, in acquire? that your that China does that volumes? they about we those you tend factor think

what your follow-up. how I'll into for volumes convert have quick as side, flip volumes? pricing you they should the And about that If that do hospitals, does And preferred those on be are just if I we not, in their may guess, headwind think one pricing? those

Thomas G. Frinzi

for the question, Thanks David. Yes.

LASIK. hospital to with be strong. with much very more is their clarify, They about systems, to not 'XX and continuing into within be SMILE bit customer. 'XX to But Aier, listen, half relationship continue lowered feel and maybe to Aier grow a so a We're has on but pricing and Aier think is I not the Aier growth certainly what price, strategy back only our we lowered first this the just and good solid of through little the competitive has our EVO we're with continuing LASIK aware year, of within half through beyond.

you as hope to doing that some color gives So how we're there.

out think our And to correction I vision competing perspective, other. Again, we noise though, with some from more is grow. there continue of the each laser

our Hospital. in certainly to very continue where as about said is broadly, share. with comments, relationship And Aier We good feel China within earlier we I our business take in my but

David Saxon

Okay. Great. if And your factors just pricing second could my on how comment kind strategy And their into of then and guidance. on I M&A guess is maybe volumes or you just follow-up then there? question

So the into growth third guidance fourth accelerates implies quarter stack least a the on basis, X-year quarter. at

third the Or So around fourth in into that X-year are quarter? is seeing stack you conservatism what acceleration you confidence that gives that quarter?

Patrick Williams

It's Patrick. David. Sure,

to think recent call did, there. it, us the there's a of think don't through, early little lot bedding to Aier, that we accounts, cetera, but of it's et I M&A you on still existing they want We're if a kind for crossover speculate.

for also closer that, pretty our last XX-ish a going reacceleration of of is terms on can that to all We head. approximately if guidance, year-over-year of to for the compared million into QX. probably hit midpoint In year. very revenue the guidance, We to strong is a growth. number trying And Tom balanced. the we of growth It We're basis do look, which QX. less $XX a know did pick million QX, is what you that think be our on that's I implies math

a that second line, is given the us it's and able and the of our this third to doing XXXX, I think, now, quarter guidance. we've on full coming raise in into top where good clearly, and the And of beat some certainly quarter we've beat year been

to a reporting XX and a for believe lot be up of second to days. ourselves forward momentum what very we next in the I strong look So half, setting

Operator

Petrone next Mizuho. will question Our with be from Anthony

Anthony Petrone

can me? I'll line. in stay Tom, you hear

Thomas G. Frinzi

Yes, we can.

Anthony Petrone

I'll maybe having the China, be how When I a so have Excellent. China. distributor? we would here. the came well. it's Excellent. X or from there. at I'll questions few X Congrats as One on maybe on months much know Maybe in there. look a good one U.S. distributors quarter into contribution now start second with

factor specifically? for that market did in play what XQ in So the STAAR

on in And was then the there China any tailwind last quick price the in quarter? China. one And

stimulus team there? after your that on on stimulus? talking anything Just just it when that. I'll And of ground U.S. the Just what relates may is to could one be timing business and have as mean enacted about for

Thomas G. Frinzi

Yes.

And I government think think first, your a question... the beyond. I feels have tell, on encouraging second some stimulus. local around of will I year question, put out continues to to this the back early and part reports to your again, impact almost part half Relative it's an it daily think basis but Chinese of too the the in first that intelligence of our

Patrick Williams

contribution. HTDK their and just

Thomas G. Frinzi

Yes.

how outright But I working think and to are a inventory has Both that certainly impact. and get with quite has it's integration in our think, integration impact having frankly, look, pleased gone and we've is of. the how a been you with top HTDK. of very terms I are how I is ability they're both line smooth, gone we're pleased care customers very Lansheng will. push, closer the outreach and getting positive if just customer And well, taken revenue, with think certainly having the our to

Patrick Williams

which said, with HTDK this they're They're we're Anthony, key, coming for I into is their feet getting word you wet. on it. the months X into months about distributors, And X but board, think both

reason beyond, even certainly, why productivity, whatever this to with and we we their from And words year, out partner see as them expanded to more close chose 'XX use. you do to the that and so to to we expect, we're and sales want force able them use, going them, efficiency,

every the then, when get with deal the move with [indiscernible] than already economics in. a that we But deal. QX. that new were factored maybe consistently and been XXX bps pretty saying baked there's course, different we into We've so pricing or tailwinds HTDK forward. to no, as able In Lansheng re-signed We pricing, terms of with nothing that of of new that's we

Thomas G. Frinzi

much congratulating on for us note, least thank a on quarter. a strong lighter at you Anthony,

first so. the to You're do

Anthony Petrone

of quarter all a been It's Absolutely. medtech around. Absolutely.

So number raising good guidance And beat race to U.S., on the see here. that contribution. U.S. just then in for

in the few example. XX a announced quarters. last Highway for number of And obviously, digging into initiative. for SharpeVision, You've one, that wins

wins account Highway linked spoke So new the increase more within just those to this over openings you is that XX? X Or this past quarters? about is

Thomas G. Frinzi

Yes.

look, Highway the think, XX growth I a undertook. was initiative versus program our at XX focused right of we our accounts in amount disproportionate Highway large. accounts seeing and We're

I accounts certainly So and agreements strategic we've initiative. it it's -- seeing the we're are signed high-profile think across having Highway their but XX impact, entire the

As growing general. accounts we're within we accounts more than said, I are significantly in those

it's I somewhere aren't our within Specifically, think growth growth XX in accounts of XX. XX% around versus that XX% part Highway Highway accounts

and board, the across the EVO ICLs are appeal it think it's just having. that proves So I

Operator

Sellers Stephens. Next George be question from with will

George Sellers

hear right? me all all You

Thomas G. Frinzi

Yes, are we How George. can, you?

George Sellers

us piece sequentially Great. to of Maybe I growth an in Highway just the commentary. color you growth important year-over-year. a with accounts? that additional on XX Congrats Obviously, both bit a driving quarter. the on the what's those stick wanted great give and U.S.. within on any dig little maybe to Can

own be buy-in in accounts on suite? curve those that any Anything on of terms spending EVO more dollars? of Is accounts there. surgical diopter helpful the have acceleration in change with would those those there Maybe Any affordability from marketing accounts? in their

Thomas G. Frinzi

Yes.

combination a to all it's think I be of honest. that, George, of

and dollars we to As level consumer how awareness. a made relative the pivot marketing driving of more we've down our it kind versus spending we practice said, to were

having impact. think an I that's

laser but had more account Highway not within an But say we XX we're vision but I pricing accounts. impact. a correction in laser confidence the laser prevailing surgeon demonstrate that had We've to maybe EVO is, closer do correction a they premium Clearly, brought line, vision doubling their with working little of certainly see to a up. increases certain adoption the go with, something correction, still practices a would that has as with pricing any vision

what but study It their around higher And encouraged and as to they've have curve in also And of So we the are volume, all only think another. the remarks, by curve. of did diopter the were come equates where within all is procedural down U.S. the we feeds showed of said starting sooner total down I we into I the prepared our that by, group we fact it rate world lot very diopter XX% we again, we the a do equates surgeon curve, all of has. on cylinders. one saw confidence any market ACO think not the -- coming surgeons and again, down than a coming again, to to the that encouraged diopter really growth, adoption, click

George Sellers

you're data what's this growth? on seeing helpful. Okay. Great. Could That's really impact perspective? the going, speak latch some clinical And of doctors XX any just to marketing there. driving outside team? really And from of where strong really you the then growth part U.S. that Highway group, with combining your still maybe that's How that's if

Thomas G. Frinzi

in I significantly, outside XX%. that as the down to is QX was around growth in somewhere look, context, I refractive U.S. Well, of XX XX% in of market the area No. our Put Highway Yes. said, XX%. think,

you that is a happy producing practice, happy in EVO keep happy So factor practice and a and when growth happy patients, again, context. makes EVO patients grow. And I that's a mean remarkable make

Patrick Williams

Yes.

not in the the such U.S. really in the George, hands put we team, tried think is the to a I I just data but And accelerate just that, clinical sales at our it to of of bit want think is whether I just asked because great leave we're to the little -- XXXX. as that it's we was about that. in question hit the revenue that a globally, things beginning one, you stages question this ability

we're it of lot talked that Tom we the working stuff working initiatives a as manner, do and lot other of it in on a hands different which well about, of as is things on. and compliant There's to types sure we're to deploy what everyone make labeling get on a of in help that

be getting things So globally down coming about going a initiatives, is force and also these to lot of sales up about that pumped excited the pipeline. we're really the are

Operator

will Young our from final take We now Canaccord. John at question

John Young

start here. second U.S. Congrats a fit you the in nice criteria? more strategic I X the for many, talked the to to Great. lane alliances if Last those How lane quarter so? identified any of this half first. And more year, just that? want quantify Have that way that plans you quarter, signing accounts. of on fast on about fast

Thomas G. Frinzi

X total year of signed against U.S. we've far target this so XX. list in John, Yes. new the about a agreements

up against we X spoke, again, So But there's more we still pending. that I last time think were XX targeted We're to a X. now list. few at

Patrick Williams

we're hear halo accounts the and starting now, that actually effect. approach to call And us we

we And DMA of it?" do one other get accounts got so saying, "How in I on the have, now we've in large

the [ So that ], again you was to it are things click plan. for always whatever you us. part nicely it, very of starting want FOMO call call to Whatever

Operator

That your for today. you the Thank participation. now concludes for call

now You disconnect. may

STAAR Surgical (STAA) 7 Aug 242024 Q2 Earnings call transcript